| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
arachidonate 5-lipoxygenase | 0.447 | 0.885 | 1.2E-06 |
|
phenotype | 0.350 | None | 1.000 | 1 | 0 | 1994 | 2018 | ||||||||
|
dihydrofolate reductase | 0.513 | 0.808 | 3.4E-02 |
|
phenotype | 0.550 | None | 1.000 | 1 | 0 | 1994 | 2019 | ||||||||
|
serpin family B member 5 | 0.582 | 0.577 | 3.6E-03 |
|
phenotype | 0.390 | None | 1.000 | 1 | 0 | 1994 | 2013 | ||||||||
|
colony stimulating factor 3 | 0.377 | 0.885 | 0.38 |
|
phenotype | 0.400 | None | 0.917 | 2 | 0 | 1995 | 2019 | ||||||||
|
MET proto-oncogene, receptor tyrosine kinase | 0.380 | 0.846 | 0.97 |
|
phenotype | 0.400 | None | 0.972 | 2 | 0 | 1995 | 2020 | ||||||||
|
CD82 molecule | 0.507 | 0.731 | 1.3E-08 |
|
phenotype | 0.600 | None | 0.973 | 1 | 0 | 1995 | 2019 | ||||||||
|
ETS variant transcription factor 4 | 0.545 | 0.500 | 2.9E-08 |
|
phenotype | 0.400 | None | 1.000 | 1 | 0 | 1995 | 2019 | ||||||||
|
vasoactive intestinal peptide | 0.437 | 0.846 | 4.2E-04 |
|
phenotype | 0.320 | None | 1.000 | 1 | 0 | 1995 | 2019 | ||||||||
|
matrix metallopeptidase 9 | 0.305 | 0.923 | 1.9E-17 |
|
phenotype | 0.600 | None | 0.991 | 5 | 0 | 1996 | 2020 | ||||||||
|
superoxide dismutase 2 | 0.379 | 0.923 | 0.15 |
|
phenotype | 0.400 | None | 1.000 | 4 | 0 | 1996 | 2019 | ||||||||
|
catalase | 0.359 | 0.962 | 1.6E-10 |
|
phenotype | 0.390 | None | 1.000 | 3 | 0 | 1996 | 2019 | ||||||||
|
thymidine phosphorylase | 0.495 | 0.769 | 1.2E-04 |
|
phenotype | 0.400 | None | 0.960 | 1 | 0 | 1996 | 2019 | ||||||||
|
secreted phosphoprotein 1 | 0.353 | 0.885 | 2.1E-06 |
|
phenotype | 0.400 | None | 0.989 | 1 | 0 | 1996 | 2020 | ||||||||
|
paxillin | 0.547 | 0.654 | 8.2E-02 |
|
phenotype | 0.400 | None | 1.000 | 1 | 0 | 1996 | 2019 | ||||||||
|
catenin beta 1 | 0.303 | 0.885 | 1.00 |
|
phenotype | 0.400 | None | 0.962 | 1 | 0 | 1996 | 2020 | ||||||||
|
fibroblast growth factor 13 | 0.514 | 0.808 | 0.89 |
|
phenotype | 0.380 | None | 0.889 | 1 | 0 | 1996 | 2019 | ||||||||
|
TNF alpha induced protein 8 | 0.601 | 0.500 | 0.38 |
|
phenotype | 0.360 | None | 0.833 | 1 | 0 | 1997 | 2018 | ||||||||
|
vimentin | 0.372 | 0.846 | 0.71 |
|
phenotype | 0.400 | None | 0.986 | 1 | 0 | 1997 | 2020 | ||||||||
|
phosphatase and tensin homolog | 0.305 | 0.923 | 0.26 |
|
phenotype | 0.400 | None | 0.976 | 1 | 0 | 1997 | 2020 | ||||||||
|
insulin like growth factor 1 | 0.318 | 0.885 | 0.27 |
|
phenotype | 0.400 | None | 1.000 | 1 | 0 | 1997 | 2019 | ||||||||
|
cAMP responsive element binding protein 1 | 0.463 | 0.885 | 1.00 |
|
phenotype | 0.400 | None | 1.000 | 1 | 0 | 1997 | 2019 | ||||||||
|
prostaglandin-endoperoxide synthase 2 | 0.314 | 0.962 | 1.00 |
|
phenotype | 0.600 | None | 0.968 | 2 | 0 | 1998 | 2020 | ||||||||
|
reversion inducing cysteine rich protein with kazal motifs | 0.547 | 0.731 | 1.9E-10 |
|
phenotype | 0.400 | None | 1.000 | 1 | 0 | 1998 | 2019 | ||||||||
|
plasminogen activator, urokinase receptor | 0.536 | 0.731 | 5.3E-03 |
|
phenotype | 0.400 | None | 1.000 | 1 | 0 | 1998 | 2017 | ||||||||
|
annexin A1 | 0.442 | 0.885 | 1.2E-07 |
|
phenotype | 0.600 | None | 0.958 | 1 | 0 | 1998 | 2019 |